<DOC>
	<DOCNO>NCT02152527</DOCNO>
	<brief_summary>Trimetazidine ( 1- [ 2,3,4-trimethoxybenzyl ] piperazine dihydrochloride ) clinically effective antianginal agent . Despite clinical success , understand trimetazidine 's mechanism action remain incomplete , particularly influence trimetazidine mitochondrial function isolate human cardiomyocytes . The investigator perform study seek possible difference mitochondrial respiration relate standard preoperative enrol trimetazidine therapy .</brief_summary>
	<brief_title>Prospective Observational Study Trimetazidine Influence Mitochondrial Metabolism Human Heart Ventricle</brief_title>
	<detailed_description>Background : Different type medication use treatment ischemic heart disease . One recently develop drug trimetazidine . Although clinical benefit clear , mechanism occur yet undefined . In animal study author try define effect trimetazidine fatty acid glucose metabolism heart . Data collect human cardiomyocytes rare . Available data suggest trimetazidine may act potent inhibitor beta oxidation , significant effect glucose oxidation . Objective : Primary objective : collection mitochondrial respiration data use human heart ventricular sample . Secondary objective : define possible difference mitochondrial respiration depend preoperative trimetazidine usage . Methods : Regularly schedule patient coronary artery bypass grafting surgery accept participate study enrol protocol . Patients inclusion criterion without exclusion criterion enrol study . At end operation , surgeon take biopsy sample leave ventricle mitochondrial function metabolic activity analysis .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Trimetazidine</mesh_term>
	<criteria>Patients coronary artery disease candidate coronary artery bypass graft ( CABG ) surgery . Emergency patient , patient already heart surgery , patient acute coronary syndrome last 2 month , patient inability understand patient information inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>